Many people are interested in the recent DEA classification of synthetic cannabinoids delta-8 and delta-9 THCO as controlled substances. In this article, we will provide you with a detailed analysis of the DEA’s decision and information on how it will impact the hemp and cannabis industries.
Delta-8 and delta-9 THC are two cannabinoids found in the cannabis plant. Delta-8 is a minor cannabinoid that occurs naturally in cannabis but only in very small amounts. Delta-9 THC is the primary psychoactive compound found in cannabis and is responsible for the “high” people experience when using marijuana.
Delta-8 and Delta-9 THCO (THC acetate ester), on the other hand, are synthetic cannabinoids not naturally expressed in cannabis or hemp.
Terrence L. Boos, Chief of the DEA’s Drug & Chemical Evaluation Section, explains that “Delta-9-THCO and delta-8-THCO do not occur naturally in the cannabis plant and can only be obtained synthetically, and therefore do not fall under the definition of hemp. Delta-9-THCO and delta-8-THCO are tetrahydrocannabinols having similar chemical structures and pharmacological activities to those contained in the cannabis plant. Thus, delta-9-THCO and delta-8-THCO meet the definition of “tetrahydrocannabinols,” Meaning that these synthetic cannabinoids fall under the same scheduling as natural Delta 9 THC found in cannabis.
The DEA’s decision to classify delta-8 and delta-9 THCO as controlled substances have caused concern in the hemp industry. This decision may mean that these cannabinoids are now subject to the same restrictions as marijuana and other controlled substances, even when synthesized from legal hemp.
Impact of THCO Ruling on Hemp and Cannabis Industries
The hemp and cannabis industries have been growing rapidly in recent years, with many companies focusing on producing hemp-derived cannabinoid products. Delta-8 THC derived from hemp has become a popular alternative to delta-9 THC, as it produces similar therapeutic effects without the same level of psychoactivity while also evading the scheduling and regulation around cannabis.
The DEA’s decision to classify THCO as a controlled substance will likely have a significant impact on the hemp industry. Many companies producing and selling delta-8 & 9 THCO products will now have to cease production, as they will no longer be legal or protected under the 2018 Farm Bill.
The impact on the cannabis industry is less clear, as most cannabis products are still illegal under federal law. However, the classification of delta-8 and delta-9 THCO as controlled substances could increase industry scrutiny and make it more difficult for cannabis companies to operate.
There is confusion surrounding the DEA’s decision to classify delta-8 and delta-9 THCO as controlled substances. Some legal experts have argued that the DEA does not have the authority to do so, as these cannabinoids are derived from legal hemp.
Several lawsuits have been filed challenging the DEA’s decisions on scheduling cannabinoids over the last twenty years, and it remains to be seen how these legal challenges will be resolved. In the meantime, many hemp and cannabis companies are taking a cautious approach and ceasing production of delta-8 & delta-9 THCO products.
Conclusion on THCO Decision
The DEA’s decision to classify delta-8 and delta-9 THCO as controlled substances has caused significant concern in the hemp and cannabis industries. This decision will likely have a substantial impact on the production and sale of THCO products and may make it more difficult for hemp companies to operate.
Despite the legal challenges, hemp and cannabis companies need to remain compliant with federal law. The future of the hemp and cannabis industries remains uncertain, but it is clear that companies must be prepared to adapt to changing regulations and legal challenges.